EP Patent

EP0494819B1 — Nouvelles phénylimidazolidines, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant

Assigned to Aventis Pharma SA · Expires 1996-07-10 · 30y expired

What this patent protects

Patent listed against Xtandi.

Drugs covered by this patent

Patent Metadata

Patent number
EP0494819B1
Jurisdiction
EP
Classification
—
Expires
1996-07-10
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.